Stocks
Health Care
stim
Neuronetics
NASDAQ: STIM
+0.15 (+10.57%)
1.5701
USD
At close at Apr 20, 18:45 UTC
Overview
Loading chart...
Key Stats
Market Cap
97.25M
Dividend Yield
0.00%
P/E Ratio
-2.49
EPS
-1.38
Revenue
74.89M
Avg. Volume
1.47M
Recently from Cashu
No Cashu articles
Neuronetics currently has no Cashu-related articles
About
What does STIM do?
Neuronetics, based in Malvern, Pennsylvania, develops the NeuroStar Advanced Therapy System, a TMS device for treating major depressive disorder. The company went public on June 28, 2018, and employs 202 people.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.